Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

baby formula

  • Home
  •  
  • baby formula



  • Most Read
  • Latest Comments
  • The shut down of one major plant caused the US baby formula crisis. Aussie companies are stepping in to help.
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • The shut down of one major plant caused the US baby formula crisis. Aussie companies are stepping in to help.
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • The shut down of one major plant caused the US baby formula crisis. Aussie companies are stepping in to help.
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • The shut down of one major plant caused the US baby formula crisis. Aussie companies are stepping in to help.
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • The shut down of one major plant caused the US baby formula crisis. Aussie companies are stepping in to help.
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Bubs enrols 400th infant in its US clinical trials to get baby formula approval
    Bubs enrols 400th infant in its US clinical trials to get baby formula approval
    • News

  • Bubs Australia rebounds in China after CEO fiasco, sees USA growth
    Bubs Australia rebounds in China after CEO fiasco, sees USA growth
    • News

  • Softer infant formula demand in Middle East, China and EU squeeze Clover’s profits
    Softer infant formula demand in Middle East, China and EU squeeze Clover’s profits
    • News

  • Jatcorp appoints Sunny Jianxin Liang as new CEO, unveils strategic growth initiatives
    Jatcorp appoints Sunny Jianxin Liang as new CEO, unveils strategic growth initiatives
    • News

  • JATCorp sues Chinese competitor for calling products “fake”, posts 186% revenue increase in September quarter
    JATCorp sues Chinese competitor for calling products “fake”, posts 186% revenue increase in September quarter
    • News

  • The shut down of one major plant caused the US baby formula crisis. Aussie companies are stepping in to help.
    • News

    The shut down of one major plant caused the US baby formula crisis. Aussie companies are stepping in to help.

    I’m convinced the commodities index should include companies that manufacture toilet rolls and now, baby formula. Seemingly rarer than hen’s teeth, the powder gold is causing major headaches for parents across the US. The limited supply isn’t solely due to COVID related logistics issues, but rather the result of a sluggish government response and wider

    Read More
    Public
  • Bubs clears regulatory pathway with breakthrough China collaboration
    • News

    Bubs clears regulatory pathway with breakthrough China collaboration

    With trade tensions between Australia and China bubbling, dairy products company Bubs Australia (ASX: BUB) has mitigated their potential risk exposure through an agreement with China-based Beingmate which will package and mass distribute their 100% Australian goats milk formula. In particular, the collaboration will seek a State Administration for Market Regulation (SAMR) brand slot which

    Read More
    Public
  • Wattle Health sign 10-year agreement with Chemist Warehouse
    • News

    Wattle Health sign 10-year agreement with Chemist Warehouse

    Infant product manufacturer, Wattle Health Australia Limited (ASX: WHA), are set to significantly expand their domestic and international distribution channels, following the news that the company has signed a long-term agreement with Chemist Warehouse to sell their organic range of baby products.  The agreement would see the drugstore network which comprises of over 300 Australian

    Read More
    Public
  • 1
  • 2

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.